These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 18667845

  • 1. Progastrin-releasing peptide: stability in plasma/serum and upper reference limit.
    Nordlund MS, Bjerner J, Warren DJ, Nustad K, Paus E.
    Tumour Biol; 2008; 29(3):204-10. PubMed ID: 18667845
    [Abstract] [Full Text] [Related]

  • 2. Stability of pro-gastrin-releasing peptide in serum versus plasma.
    Yoshimura T, Fujita K, Kawakami S, Takeda K, Chan S, Beligere G, Dowell B.
    Tumour Biol; 2008; 29(4):224-30. PubMed ID: 18781094
    [Abstract] [Full Text] [Related]

  • 3. Enzyme immunoassay of immunoreactive progastrin-releasing peptide(31-98) as tumor marker for small-cell lung carcinoma: development and evaluation.
    Aoyagi K, Miyake Y, Urakami K, Kashiwakuma T, Hasegawa A, Kodama T, Yamaguchi K.
    Clin Chem; 1995 Apr; 41(4):537-43. PubMed ID: 7720242
    [Abstract] [Full Text] [Related]

  • 4. Multicenter evaluation of a new progastrin-releasing peptide (ProGRP) immunoassay across Europe and China.
    Korse CM, Holdenrieder S, Zhi XY, Zhang X, Qiu L, Geistanger A, Lisy MR, Wehnl B, van den Broek D, Escudero JM, Standop J, Hu M, Molina R.
    Clin Chim Acta; 2015 Jan 01; 438():388-95. PubMed ID: 25262909
    [Abstract] [Full Text] [Related]

  • 5. Expression of progastrin-releasing peptide and gastrin-releasing peptide receptor mRNA transcripts in tumor cells of patients with small cell lung cancer.
    Uchida K, Kojima A, Morokawa N, Tanabe O, Anzai C, Kawakami M, Eto Y, Yoshimura K.
    J Cancer Res Clin Oncol; 2002 Dec 01; 128(12):633-40. PubMed ID: 12474049
    [Abstract] [Full Text] [Related]

  • 6. Enzyme-linked immunosorbent assay of pro-gastrin-releasing peptide for small cell lung cancer patients in comparison with neuron-specific enolase measurement.
    Yamaguchi K, Aoyagi K, Urakami K, Fukutani T, Maki N, Yamamoto S, Otsubo K, Miyake Y, Kodama T.
    Jpn J Cancer Res; 1995 Jul 01; 86(7):698-705. PubMed ID: 7559089
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. ProGRP: a new biomarker for small cell lung cancer.
    Molina R, Filella X, Augé JM.
    Clin Biochem; 2004 Jul 01; 37(7):505-11. PubMed ID: 15234231
    [Abstract] [Full Text] [Related]

  • 9. Complementary roles of pro-gastrin-releasing peptide (ProGRP) and neuron specific enolase (NSE) in diagnosis and prognosis of small-cell lung cancer (SCLC).
    Shibayama T, Ueoka H, Nishii K, Kiura K, Tabata M, Miyatake K, Kitajima T, Harada M.
    Lung Cancer; 2001 Apr 01; 32(1):61-9. PubMed ID: 11282430
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A continuous responder algorithm to optimize clinical management of small-cell lung cancer with progastrin-releasing peptide as a simple blood test.
    Muley T, Zhang X, Holdenrieder S, Korse CM, Zhi XY, Molina R, Liu Z, Hartmann G, van den Heuvel MM, Qian K, Marrades R, Engel C, He Y, Wehnl B, Dayyani F, Herth F.
    Tumour Biol; 2020 Sep 01; 42(9):1010428320958603. PubMed ID: 32964798
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Pro-gastrin-releasing peptide (ProGRP)--a useful marker in small cell lung carcinomas.
    Stieber P, Dienemann H, Schalhorn A, Schmitt UM, Reinmiedl J, Hofmann K, Yamaguchi K.
    Anticancer Res; 1999 Sep 01; 19(4A):2673-8. PubMed ID: 10470218
    [Abstract] [Full Text] [Related]

  • 15. Pro-gastrin-releasing peptide(31-98) is a specific tumor marker in patients with small cell lung carcinoma.
    Miyake Y, Kodama T, Yamaguchi K.
    Cancer Res; 1994 Apr 15; 54(8):2136-40. PubMed ID: 8174119
    [Abstract] [Full Text] [Related]

  • 16. Diagnostic and therapeutic value of progastrin-releasing peptide on small-cell lung cancer: A Single-Center Experience in China.
    Wu XY, Hu YB, Li HJ, Wan B, Zhang CX, Zhang B, Hu H, Zhang Q, Lv TF, Zhan P, Song Y.
    J Cell Mol Med; 2018 Sep 15; 22(9):4328-4334. PubMed ID: 29989303
    [Abstract] [Full Text] [Related]

  • 17. The influence of different blood samples treatment methods on pro-gastrin-releasing peptide.
    Jiang H, Luo L, Xiong K, He C, Wang H, Qin Y.
    Medicine (Baltimore); 2019 Jun 15; 98(26):e16130. PubMed ID: 31261534
    [Abstract] [Full Text] [Related]

  • 18. Serum progastrin-releasing peptide levels followed by whole-body positron emission tomography detects early recurrence of small-cell lung cancer.
    Yamaguchi H, Soda H, Kitazaki T, Nakano H, Fujino S, Nakamura Y, Kohno S.
    Respirology; 2007 Jan 15; 12(1):137-9. PubMed ID: 17207039
    [Abstract] [Full Text] [Related]

  • 19. [Establishment of cut-off value of serum pro-gastrin-releasing peptide for diagnosis of small cell lung cancer and evaluation on the clinical diagnosis efficiency].
    Shen D, Han BB, Chen F, Wei BJ, Cui CJ, Wang GJ, Cui W.
    Zhonghua Yi Xue Za Zhi; 2017 Sep 12; 97(34):2657-2662. PubMed ID: 28910952
    [Abstract] [Full Text] [Related]

  • 20. Clinicopathological findings of non-small-cell lung cancer with high serum progastrin-releasing peptide concentrations.
    Kudo K, Ohyanagi F, Horiike A, Miyauchi E, Yanagitani N, Hoshi R, Satoh Y, Motoi N, Hamanaka W, Ishikawa Y, Mun M, Sakao Y, Okumura S, Nakagawa K, Horai T, Nishio M.
    Lung Cancer; 2011 Dec 12; 74(3):401-4. PubMed ID: 21529988
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.